ADCT logo ADC Therapeutics : ADCT

ADCT

Stock Data

$3.62

Change up

$0.07 (1.97%)

Asset Type

Common Stock

Exchange

NYSE

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

ADC Therapeutics SA is a biotechnology firm focused on developing treatments for cancer. It specializes in creating antibody drug conjugates (ADCs) aimed at combating hematological malignancies and solid tumors. Its leading product, ZYNLONTA, is undergoing trials for specific lymphoma conditions. The company is also working on several other ADCs targeting various cancers, including a notable project in Hodgkin lymphoma and treatments for solid tumors and leukemia. Founded in 2011 and based in Switzerland, ADC Therapeutics collaborates with several global entities to advance its research and development efforts.

All ADC Therapeutics Articles

21 Articles

1 2

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.